Jabil's diversification in end markets like Auto & Transportation and Healthcare & Packaging is a positive factor for revenue growth. However, the 17% YoY decline in Q1 2025 and lack of specialization in specific markets limit its ability to outpace the EMS market. The broad geographic footprint and supplier base are advantageous for risk management and cost efficiency, balancing the negative impact of the revenue decline.